Dent Disease Clinical Trial
Official title:
Role Of Phosphorus And FGF 23 In Patients With Dent Disease
Patients with Dent disease have suppressed levels of FGF 23 which contributes to hypercalciuria, kidney stones, nephrocalcinosis and renal failure. Supplementation with phosphorus may reduce hypercalciuria.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02022189 -
Review of Kidney Biopsies of Dent Disease Patients
|
N/A | |
Recruiting |
NCT06065852 -
National Registry of Rare Kidney Diseases
|
||
Recruiting |
NCT02780297 -
Prospective Research Rare Kidney Stones (ProRKS)
|
||
Recruiting |
NCT02026388 -
Rare Kidney Stone Consortium Biobank
|
||
Completed |
NCT04459013 -
Evaluation of the Release of Monomers From Composite Bonding Resins in Orthodontics
|
||
Not yet recruiting |
NCT06017193 -
Ultrasound for Socket Healing Evaluation
|
||
Recruiting |
NCT00588562 -
Rare Kidney Stone Consortium Patient Registry
|
||
Completed |
NCT02124395 -
Health-related Quality of Life in Rare Kidney Stone
|
||
Completed |
NCT01783795 -
Dent Disease Mutation Genotyping
|
N/A |